ProfileGDS4718 / 211709_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 43% 62% 33% 39% 57% 67% 50% 49% 40% 42% 50% 57% 65% 62% 54% 51% 68% 62% 64% 57% 56% 53% 52% 39% 60% 42% 63% 40% 54% 53% 61% 48% 46% 65% 67% 59% 54% 45% 75% 49% 61% 85% 64% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1139342
GSM549102patient 115, normal, homogenized [OPG study]5.1436443
GSM549104patient 119, normal, homogenized [OPG study]6.3052462
GSM549108patient 138, normal, homogenized [OPG study]4.7141733
GSM549119patient 077, normal, homogenized [OPG study]4.9629939
GSM549133patient 032, cancer, homogenized [OPG study]5.91557
GSM549139patient 042, cancer, homogenized [OPG study]6.6326467
GSM549099patient 107, normal, homogenized [OPG study]5.5391850
GSM549109patient 139, normal, homogenized [OPG study]5.4612549
GSM549110patient 046, normal, homogenized [OPG study]5.0068340
GSM549114patient 063, normal, homogenized [OPG study]5.0584742
GSM549122patient 082, normal, homogenized [OPG study]5.5279250
GSM549134patient 033, cancer, homogenized [OPG study]5.9173157
GSM549136patient 036, cancer, homogenized [OPG study]6.4824165
GSM549140patient 044, cancer, homogenized [OPG study]6.2559862
GSM549111patient 047, normal, homogenized [OPG study]5.7312554
GSM549113patient 057, normal, homogenized [OPG study]5.5375251
GSM549132patient 031, cancer, homogenized [OPG study]6.7013568
GSM549137patient 038, cancer, homogenized [OPG study]6.2918262
GSM549142patient 047, cancer, homogenized [OPG study]6.4350664
GSM549100patient 110, normal, homogenized [OPG study]5.9326257
GSM549107patient 135, normal, homogenized [OPG study]5.828856
GSM549115patient 068, normal, homogenized [OPG study]5.6098553
GSM549116patient 072, normal, homogenized [OPG study]5.5924852
GSM549120patient 078, normal, homogenized [OPG study]4.9274339
GSM549131patient 030, cancer, homogenized [OPG study]6.0818460
GSM549118patient 074, normal, homogenized [OPG study]5.1031142
GSM549129patient 027, cancer, homogenized [OPG study]6.345363
GSM549123patient 088, normal, homogenized [OPG study]4.9619940
GSM549124patient 006, cancer, homogenized [OPG study]5.761254
GSM549126patient 015, cancer, homogenized [OPG study]5.6915753
GSM549128patient 025, cancer, homogenized [OPG study]6.2148461
GSM549103patient 117, normal, homogenized [OPG study]5.4401148
GSM549117patient 073, normal, homogenized [OPG study]5.2513346
GSM549138patient 041, cancer, homogenized [OPG study]6.473565
GSM549141patient 045, cancer, homogenized [OPG study]6.6651367
GSM549130patient 028, cancer, homogenized [OPG study]6.0852159
GSM549101patient 111, normal, homogenized [OPG study]5.7996754
GSM549105patient 128, normal, homogenized [OPG study]5.2734645
GSM549106patient 134, normal, homogenized [OPG study]7.4315975
GSM549112patient 048, normal, homogenized [OPG study]5.4734549
GSM549125patient 011, cancer, homogenized [OPG study]6.1634761
GSM549127patient 024, cancer, homogenized [OPG study]8.453985
GSM549135patient 035, cancer, homogenized [OPG study]6.4051864